-
Subject Areas on Research
-
3-D computer visualization and interactive prostate biopsy simulation leads to an improved systematic technique for the detection of prostate cancer: clinical correlation.
-
3Din vivodose verification in prostate proton therapy with deep learning-based proton-acoustic imaging.
-
7alpha,11beta-Dimethyl-19-nortestosterone: a potent and selective androgen response modulator with prostate-sparing properties.
-
A Case of Fatal Clostridial Necrotizing Fasciitis After Radical Prostatectomy.
-
A Hybrid Human-Machine Learning Approach for Screening Prostate Biopsies Can Improve Clinical Efficiency Without Compromising Diagnostic Accuracy.
-
A Multi-Institutional Prospective Trial Confirms Noninvasive Blood Test Maintains Predictive Value in African American Men.
-
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.
-
A Review of Prostate Biopsy Techniques.
-
A coaxial microwave applicator for transurethral hyperthermia of the prostate.
-
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.
-
A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate.
-
A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
-
A novel conditionally replicative adenovirus vector targeting telomerase-positive tumor cells.
-
A novel in vitro assay of tumor-initiating cells in xenograft prostate tumors.
-
A novel neoplastic primary tumor-derived human prostate epithelial cell line.
-
A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate.
-
A quantitative method for measuring gene expression magnitude and volume delivered by gene therapy vectors.
-
A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion.
-
A seminal finding for prostate cancer?
-
A three-dimensional deformable model for segmentation of human prostate from ultrasound images.
-
ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.
-
Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin-mediated prostatic tumorigenesis.
-
Accurate determination of prostate size via digital rectal examination and transrectal ultrasound.
-
Acoustic radiation force impulse imaging of human prostates ex vivo.
-
Acoustic radiation force impulse imaging of human prostates: initial in vivo demonstration.
-
Activation of the PKB/Akt pathway in histological benign prostatic tissue adjacent to the primary malignant lesions.
-
Active surveillance for prostate cancer: can we modernize contemporary protocols to improve patient selection and outcomes in the focal therapy era?
-
Adenocarcinoma of the prostate. Part II: Tissue prognosticators.
-
Adrenocortical hyperplasia occurring with metastatic carcinoma of the prostate: report of a case exhibiting increased urinary aldosterone and glucocorticoid excretion.
-
Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted?
-
After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
-
Aggressive prostate cancer masquerading as acute prostatitis.
-
Alcohol intake increases high-grade prostate cancer risk among men taking dutasteride in the REDUCE trial.
-
An automated intensity-weighted brachytherapy seed localization algorithm.
-
An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer.
-
Androgen and androgen receptor antagonist responsive primary African-American benign prostate epithelial cell line.
-
Androgen control of an inhibitory modulator of phosphodiesterase in rat epididymis and prostate.
-
Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.
-
Androgen receptor with short polyglutamine tract preferably enhances Wnt/β-catenin-mediated prostatic tumorigenesis.
-
Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation.
-
Androgen-independent prostate cancer progression in the TRAMP model.
-
Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy.
-
Anterior gland focal cryoablation: proof-of-concept primary prostate cancer treatment in select men with localized anterior cancers detected by multi-parametric magnetic resonance imaging.
-
Antigenic activity of human urothelial tissue.
-
Apical surgical margins status in robot-assisted laparoscopic radical prostatectomy does not depend on disease characteristics.
-
Application of dose compensation in image-guided radiotherapy of prostate cancer.
-
Arc-modulated radiation therapy based on linear models.
-
Aspiration biopsy of prostate.
-
Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three-dimensional transperineal template mapping histopathology.
-
Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
-
Association between Agent Orange and prostate cancer: a pilot case-control study.
-
Association between Delay to Radical Prostatectomy and Clinically Meaningful Outcomes among Patients with Intermediate and High-Risk Localized Prostate Cancer.
-
Association between preoperative erectile dysfunction and prostate cancer features--an analysis from the Duke Prostate Center Database.
-
Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor.
-
B-mode and acoustic radiation force impulse (ARFI) imaging of prostate zonal anatomy: comparison with 3T T2-weighted MR imaging.
-
Baseline Prostate Atrophy is Associated with Reduced Risk of Prostate Cancer in Men Undergoing Repeat Prostate Biopsy.
-
Benign prostatic hypertrophy and uterine leiomyomas: analogous or dissimilar diseases?
-
Bilateral focal ablation of prostate tissue using low-energy direct current (LEDC): a preclinical canine study.
-
Biologically effective dose (BED) correlation with biochemical control after low-dose rate prostate brachytherapy for clinically low-risk prostate cancer.
-
Biomarkers Accurately Inform Treatment Decisions in Localized Prostate Cancer.
-
Can RECIST response predict success in phase 3 trials in men with metastatic castration-resistant prostate cancer?
-
Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?
-
Characterization of a "low-risk" cohort of grade group 2 prostate cancer patients: Results from the Shared Equal Access Regional Cancer Hospital database.
-
Characterization of a new model of human prostatic cancer: the multicellular tumor spheroid.
-
Characterization of alpha-1 adrenoceptor subtypes in human and canine prostate membranes.
-
Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium.
-
Characterizing stiffness of human prostates using acoustic radiation force.
-
Clarifying the Relative Impacts of Vascular and Nerve Injury That Culminate in Erectile Dysfunction in a Pilot Study Using a Rat Model of Prostate Irradiation and a Thrombopoietin Mimetic.
-
Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density.
-
Comparative Effectiveness and Tolerability of Transperineal MRI-Targeted Prostate Biopsy under Local versus Sedation.
-
Comparison of Cost and Perioperative Outcomes Among Patients Undergoing Simple Prostatectomy and Laser Enucleation of the Prostate.
-
Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
-
Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities.
-
Comparison of ultrasound-guided biopsies and prostatectomy specimens: predictive accuracy of Gleason score and tumor site.
-
Computed high b-value diffusion-weighted imaging improves lesion contrast and conspicuity in prostate cancer.
-
Constructing and Pilot Testing a Novel Prostate Magnetic Resonance Imaging/Ultrasound Fusion Biopsy Phantom.
-
Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer.
-
Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound.
-
Correlation of DNA ploidy and histologic diagnosis from prostate core-needle biopsies: is DNA ploidy more sensitive than histology for the diagnosis of carcinoma in small specimens?
-
Cost comparison of radical retropubic and radical perineal prostatectomy: single institution experience.
-
Cryptococcosis.
-
DHX15 is up-regulated in castration-resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations.
-
Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy.
-
Defects of prostate development and reproductive system in the estrogen receptor-alpha null male mice.
-
Defining the Incremental Utility of Prostate Multiparametric Magnetic Resonance Imaging at Standard and Specialized Read in Predicting Extracapsular Extension of Prostate Cancer.
-
Definitive external beam irradiation in stage T1 and T2 carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
-
Detection of oncornavirus antigenic activity in human urothelial tissues.
-
Detection of previously unidentified metastatic disease as a leading cause of screening failure in a phase III trial of zibotentan versus placebo in patients with nonmetastatic, castration resistant prostate cancer.
-
Detection of prostate cancer with multiparametric MRI (mpMRI): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis.
-
Development and clinical evaluation of a three-dimensional cone-beam computed tomography estimation method using a deformation field map.
-
Developmental biology. Branching takes nerve.
-
Diagnostic Properties of Total and Free Prostate-Specific Antigen to Predict Overall and Clinically Significant Prostate Cancer Among Men With Low Testosterone and Prior Negative Biopsy.
-
Diagnostic accuracy of prostate needle biopsy.
-
Dietary inflammatory index (DII) and risk of prostate cancer in a case-control study among Black and White US Veteran men.
-
Differential immunoreactivity of her-2/neu oncoprotein in prostatic tissues.
-
Diseases of the prostate.
-
Distinct function of estrogen receptor α in smooth muscle and fibroblast cells in prostate development.
-
Does Early Prostate Specific Antigen Doubling Time after Radical Prostatectomy, Calculated Prior to Prostate Specific Antigen Recurrence, Correlate with Prostate Cancer Outcomes? A Report from the SEARCH Database Group.
-
Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
-
Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy?
-
Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy.
-
Dosimetric effect of intrafraction motion and residual setup error for hypofractionated prostate intensity-modulated radiotherapy with online cone beam computed tomography image guidance.
-
Dynamic nucleosome landscape elicits a noncanonical GATA2 pioneer model.
-
E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer.
-
EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer.
-
ERAP75 functions as a coactivator to enhance estrogen receptor alpha transactivation in prostate stromal cells.
-
Early-Life Alcohol Intake and High-Grade Prostate Cancer: Results from an Equal-Access, Racially Diverse Biopsy Cohort.
-
Editorial Comment.
-
Editorial Comment.
-
Editorial comment.
-
Effects of neoadjuvant hormonal therapy on prostate biopsy results after (125)I and (103)Pd seed implantation.
-
Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients.
-
Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy.
-
Enforced expression of FGF-7 promotes epithelial hyperplasia whereas a dominant negative FGFR2iiib promotes the emergence of neuroendocrine phenotype in prostate glands of transgenic mice.
-
Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
-
Erectile function outcome reporting after clinically localized prostate cancer treatment.
-
Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy.
-
Estrogens and prostate cancer.
-
Ethnic variation in prostate cancer detection: a feasibility study for use of the Stockholm3 test in a multiethnic U.S. cohort.
-
Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: an intra- and interobserver study.
-
Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer.
-
Evidence for a novel hybrid immunotoxin recognizing ricin A-chain by one antigen-combining site and a prostate-restricted antigen by the remaining antigen-combining site: potential for immunotherapy.
-
Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future.
-
Exploring the Margin Recipe for Online Adaptive Radiation Therapy for Intermediate-Risk Prostate Cancer: An Intrafractional Seminal Vesicles Motion Analysis.
-
Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.
-
External validation of the SEARCH model for predicting aggressive recurrence after radical prostatectomy: results from the Duke Prostate Center Database.
-
Feasibility study of an intensity-modulated radiation model for the study of erectile dysfunction.
-
Financial Margins for Prostate Cancer Surgery: Quantifying the Impact of Modifiable Cost Inputs in an Episode Based Reimbursement Model.
-
Fine-tuning robot-assisted radical prostatectomy planning with MRI.
-
Flow cytometric analysis of comedocarcinoma of the prostate: an uncommon histopathological variant of prostatic adenocarcinoma.
-
Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy.
-
Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression.
-
Focal therapy for prostate cancer: pathologic basis.
-
Focal therapy in prostate cancer-report from a consensus panel.
-
Focal therapy of prostate and kidney cancer.
-
Focal therapy of prostate cancer: making steady progress toward a first-line image-guided treatment modality.
-
Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting.
-
Frontiers in Genitourinary Pathology.
-
GENIS: gene expression of sodium iodide symporter for noninvasive imaging of gene therapy vectors and quantification of gene expression in vivo.
-
Generation of full-length cDNA libraries enriched for differentially expressed genes.
-
Genetic factors influencing prostate cancer risk in Norwegian men.
-
Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer.
-
Geographic Differences in Baseline Prostate Inflammation and Relationship with Subsequent Prostate Cancer Risk: Results from the Multinational REDUCE Trial.
-
Geometric and dosimetric evaluations of an online image-guidance strategy for 3D-CRT of prostate cancer.
-
Germline mutations in HOXB13 and prostate-cancer risk.
-
Germline mutations in PPFIBP2 are associated with lethal prostate cancer.
-
Gli Transcription Factors Mediate the Oncogenic Transformation of Prostate Basal Cells Induced by a Kras-Androgen Receptor Axis.
-
Glutathione and glutathione S-transferase in benign and malignant prostate cell lines and prostate tissues.
-
Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study.
-
Gonadotropin-releasing hormone agonist overuse: urologists' response to reimbursement and characteristics associated with persistent overuse.
-
H-ProSeg: Hybrid ultrasound prostate segmentation based on explainability-guided mathematical model.
-
High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.
-
Histologic grade, DNA ploidy, and intraglandular tumor extent as indicators of tumor progression of clinical stage B prostatic carcinoma. A direct comparison.
-
How I Use It: The Exosome Diagnostics (EPI) prostate cancer biomarker utility in urology and primary care.
-
Human G(alpha q): cDNA and tissue distribution.
-
Identification and characterization of proximal 6q deletions in prostate cancer.
-
Identification of a cell of origin for human prostate cancer.
-
Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men.
-
Identification, quantification, and localization of mRNA for three distinct alpha 1 adrenergic receptor subtypes in human prostate.
-
Identifying Clinically Significant Prostate Cancers using 3-D In Vivo Acoustic Radiation Force Impulse Imaging with Whole-Mount Histology Validation.
-
Immunoreactive prostatic specific antigen in male periurethral glands.
-
Impact of primary Gleason grade on risk stratification for Gleason score 7 prostate cancers.
-
Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital.
-
Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system.
-
In vitro cultivation of prostatic epithelium.
-
In vitro culture of epithelial cells derived from urogenital tissues.
-
In-Depth Characterization and Validation of Human Urine Metabolomes Reveal Novel Metabolic Signatures of Lower Urinary Tract Symptoms.
-
Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma.
-
Induction of mitogenic signalling in the 1LN prostate cell line on exposure to submicromolar concentrations of cadmium+.
-
Inferences about prostate intrafraction motion from pre- and posttreatment volumetric imaging.
-
Inflammation on Prostate Needle Biopsy is Associated with Lower Prostate Cancer Risk: A Meta-Analysis.
-
Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration.
-
Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy.
-
Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy.
-
Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men.
-
Integrated analysis identifies a class of androgen-responsive genes regulated by short combinatorial long-range mechanism facilitated by CTCF.
-
Interexaminer reliability and validity of a three-dimensional model to assess prostate volume by digital rectal examination.
-
Interexaminer reliability of transrectal ultrasound for estimating prostate volume.
-
Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy.
-
Interrupted versus Continuous Suturing for Vesicourethral Anastomosis During Radical Prostatectomy: A Systematic Review and Meta-analysis.
-
Intratumoral inflammation is associated with more aggressive prostate cancer.
-
Investigating 3D tumor distribution for optimized diagnosis of prostate cancer.
-
Investigating the heterogeneity of viscoelastic properties in prostate cancer using MR elastography at 9.4T in fresh prostatectomy specimens.
-
Investigation of phosphoprotein signatures of archived prostate cancer tissue specimens via proteomic analysis.
-
Isolation and characterization of a novel human prostatic stromal cell culture: DuK50.
-
KLK3 germline mutation I179T complements DNA repair genes for predicting prostate cancer progression.
-
Lactoferrin gene expression is estrogen responsive in human and rhesus monkey endometrium.
-
Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort.
-
Loss of androgen signaling in mesenchymal sonic hedgehog responsive cells diminishes prostate development, growth, and regeneration.
-
Loss of epithelial oestrogen receptor α inhibits oestrogen-stimulated prostate proliferation and squamous metaplasia via in vivo tissue selective knockout models.
-
Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer.
-
Loss of uteroglobin expression in prostate cancer: relationship to advancing grade.
-
Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome.
-
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer.
-
Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology.
-
Magnetic resonance spectroscopic studies of the prostate.
-
Malakoplakia of the prostate on needle core biopsy: a case report and review of the literature.
-
Mapping of m6A and Its Regulatory Targets in Prostate Cancer Reveals a METTL3-Low Induction of Therapy Resistance.
-
Massive locally extensive prostate cancer.
-
Mechanism of Action of the Transobturator Sling for Post-Radical Prostatectomy Incontinence: A Multi-institutional Prospective Study Using Dynamic Magnetic Resonance Imaging.
-
Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer.
-
Medrogestone: a prospective study in the pharmaceutical management of benign prostatic hyperplasia.
-
Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance.
-
Metformin use and risk of prostate cancer: results from the REDUCE study.
-
Monoclonal antibodies to different epitopes on a prostate tumor-associated antigen. Implications for immunotherapy.
-
Monoclonal antibodies to tissue-associated antigens as antitumor reagents.
-
Monoclonal antibodies to tissue-specific cell surface antigens. I. Characterization of an antibody to a prostate tissue antigen.
-
Morphologic Spectrum of Neuroendocrine Tumors of the Prostate: An Updated Review.
-
Morphologic and immunologic studies of human prostatic carcinoma.
-
Most Gleason 8 Biopsies are Downgraded at Prostatectomy-Does 4 + 4 = 7?
-
Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.
-
Multiparametric Prostate MR Imaging: Impact on Clinical Staging and Decision Making.
-
Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance.
-
Nerve-sparing focal cryoablation of prostate cancer.
-
New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
-
New techniques in quantitative mass spectrometry.
-
Normal prostate and adjacent structures: MR imaging at 1.5 T.
-
Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension.
-
Number and orientations of beams in intensity-modulated radiation treatments.
-
Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans.
-
Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
-
Obesity and survival after radical prostatectomy: A 10-year prospective cohort study.
-
Obesity, race, and long-term prostate cancer outcomes.
-
Observations of tissue response to acoustic radiation force: opportunities for imaging.
-
Oncological and Functional Outcomes of Patients Undergoing Individualized Partial Gland Cryoablation of the Prostate: A Single-Institution Experience.
-
Oncological and functional outcomes of men undergoing primary whole gland cryoablation of the prostate: A 20-year experience.
-
Optimized prostate biopsy via a statistical atlas of cancer spatial distribution.
-
Optimizing monoscopic kV fluoro acquisition for prostate intrafraction motion evaluation.
-
Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial.
-
Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling.
-
Over half of contemporary clinical Gleason 8 on prostate biopsy are downgraded at radical prostatectomy.
-
PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer.
-
PDEF in prostate cancer.
-
PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer.
-
Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer.
-
Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance.
-
Patterns of Prostate-Specific Antigen Testing and Prostate Biopsies During the COVID-19 Pandemic.
-
Patterns of inpatient care for prostate cancer in men with spina bifida.
-
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas.
-
Pentosan polysulfate decreases prostate smooth muscle proliferation and extracellular matrix turnover.
-
Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer.
-
Pilot Study Evaluating a Rat Model of Radiation-induced Erectile Dysfunction Using an Image-guided Microirradiator.
-
Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen.
-
Platinum sensitivity in metastatic prostate cancer: does histology matter?
-
Possible mechanism for seeding of tumor during radical prostatectomy.
-
Post-treatment prostate MRI.
-
Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution.
-
Predicting biopsy-proven prostate cancer recurrence following cryosurgery.
-
Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.
-
Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended.
-
Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy.
-
Predictors of operative time during radical retropubic prostatectomy and robot-assisted laparoscopic prostatectomy.
-
Preventing pain during office biopsy of the prostate: a single center, prospective, double-blind, 3-arm, parallel group, randomized clinical trial.
-
Prognostic significance of DNA ploidy in carcinoma of prostate.
-
Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q.
-
Prospective use of free PSA to avoid repeat prostate biopsies in men with elevated total PSA.
-
Prostate Cancer Detection Rate of Freehand versus 3-Dimensional Template Mapping Biopsy Using a Magnetic Resonance Imaging-Ultrasound Fusion Device in Biopsy Naïve Men.
-
Prostate Cancer Disseminated Tumor Cells are Rarely Detected in the Bone Marrow of Patients with Localized Disease Undergoing Radical Prostatectomy across Multiple Rare Cell Detection Platforms.
-
Prostate MRI Qualification: AJR Expert Panel Narrative Review.
-
Prostate MRI in Stereotactic Body Radiation Treatment Planning and Delivery for Localized Prostate Cancer.
-
Prostate Specific Antigen Density as a Predictor of Clinically Significant Prostate Cancer When the Prostate Specific Antigen is in the Diagnostic Gray Zone: Defining the Optimum Cutoff Point Stratified by Race and Body Mass Index.
-
Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men.
-
Prostate biopsy in selecting candidates for hemiablative focal therapy.
-
Prostate biopsy protocols: 3D visualization-based evaluation and clinical correlation.
-
Prostate cancer antigen 3 to select men for prostate biopsy: stop, go, or proceed with caution?
-
Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer.
-
Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors.
-
Prostate diffusion imaging with distortion correction.
-
Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay.
-
Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model.
-
Prostate intrafraction motion assessed by simultaneous kV fluoroscopy at MV delivery II: adaptive strategies.
-
Prostate intrafraction motion assessed by simultaneous kilovoltage fluoroscopy at megavoltage delivery I: clinical observations and pattern analysis.
-
Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study.
-
Prostate specific antigen only progression of prostate cancer.
-
Prostate-specific membrane antigen-targeted theranostics: past, present, and future approaches.
-
Prostate. III--A structural feature characteristic of the rat prostate 5 alpha-reductase active site.
-
Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.
-
Prostatic disorders: MR imaging at 1.5 T.
-
Purification and direct transformation of epithelial progenitor cells from primary human prostate.
-
Quantification of prostate and seminal vesicle interfraction variation during IMRT.
-
Quantitative expression profile of PSGR in prostate cancer.
-
Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes.
-
RARP in high-risk prostate cancer: use of multi-parametric MRI and nerve sparing techniques.
-
Race does not predict the development of metastases in men with nonmetastatic castration-resistant prostate cancer.
-
Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy.
-
Radiation-induced erectile dysfunction using prostate-confined modern radiotherapy in a rat model.
-
Radical prostatectomy versus observation for localized prostate cancer.
-
Radical prostatectomy: value of prostate MRI in surgical planning.
-
Radical retropubic prostatectomy: the influence of accessory pudendal arteries on the recovery of sexual function.
-
Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.
-
Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy.
-
Reassessing the diagnostic yield of saturation biopsy of the prostate.
-
Reconciling Discordance Between Prostate Biopsy Histology and Magnetic Resonance Imaging Suspicion - Implementation of a Quality Improvement Protocol of Imaging Re-review and Reverse-fusion Target Analysis.
-
Reduced Core Targeted (RCT) biopsy: Combining multiparametric magnetic resonance imaging - transrectal ultrasound fusion targeted biopsy with laterally-directed sextant biopsies - An alternative template for prostate fusion biopsy.
-
Reduced prostate branching morphogenesis in stromal fibroblast, but not in epithelial, estrogen receptor α knockout mice.
-
Regulation of the beta 2-adrenergic receptor and its mRNA in the rat ventral prostate by testosterone.
-
Relationship of serum sex-steroid hormones and prostate volume in African American men.
-
Report from Durham.
-
Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage.
-
Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications.
-
Robot-assisted laparoscopic prostatectomy is not associated with early postoperative radiation therapy.
-
Role of oxidative stress in a rat model of radiation-induced erectile dysfunction.
-
Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel.
-
Scanning and transmission electron microscopy of human prostatic acinar cells.
-
Scanning electron microscopy of hyperplastic and neoplastic human prostate.
-
Screening for prostate cancer in high risk populations.
-
Seminal vesicle intraepithelial involvement by prostate cancer: putative mechanism and clinicopathological significance.
-
Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value.
-
Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data.
-
Serum metabolomic analysis of men on a low-carbohydrate diet for biochemically recurrent prostate cancer reveals the potential role of ketogenesis to slow tumor growth: a secondary analysis of the CAPS2 diet trial.
-
Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density.
-
Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors.
-
Short-term functional outcomes and complications associated with transperineal template prostate mapping biopsy.
-
Similarities between static and rotational intensity-modulated plans.
-
Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival.
-
Sleep quality and prostate cancer aggressiveness: Results from the REDUCE trial.
-
Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic Tagging.
-
Smoking is a predictor of adverse pathological features at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database.
-
Somatic innervation of the feline lower urinary tract.
-
Staging evaluation for patients with adenocarcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
-
Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial.
-
Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.
-
Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels.
-
Stromal androgen signaling acts as tumor niches to drive prostatic basal epithelial progenitor-initiated oncogenesis.
-
Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling.
-
Structured approach to resolving discordance between PI-RADS v2.1 score and targeted prostate biopsy results: an opportunity for quality improvement.
-
Successful Diagnosis and Treatment of Occult Prostate Cancer Despite Multiple Negative Prostate Biopsies and Negative Prostate MRIs.
-
Symptom and function profiles of men with localized prostate cancer.
-
Systematic biopsies: do they add prognostic information in men with clinically localized prostate cancer treated with radiation therapy alone?
-
Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer.
-
TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation.
-
Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply?
-
Targeted prostate biopsy using statistical image analysis.
-
Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer.
-
Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation.
-
Temporal relationships of statin and terminin expression in ventral lobe of rat prostate following castration.
-
Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.
-
The 17-Gene Genomic Prostate Score Test Is Prognostic for Outcomes After Primary External Beam Radiation Therapy in Men With Clinically Localized Prostate Cancer.
-
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.
-
The Association between Phosphodiesterase Type 5 Inhibitors and Prostate Cancer: Results from the REDUCE Study.
-
The Association of Previous Prostate Biopsy Related Complications and the Type of Complication with Patient Compliance with Rebiopsy Scheme.
-
The Role of Opioids and Their Receptors in Urological Malignancy: A Review.
-
The alpha 1C-adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell types.
-
The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression.
-
The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases.
-
The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
-
The gene encoding vitamin K-dependent anticoagulant protein C is expressed in human male reproductive tissues.
-
The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo.
-
The optimisation of wedge filters in radiotherapy of the prostate.
-
The prognostic value of digital rectal exam for the existence of advanced pathologic features after prostatectomy.
-
The role of Alzheimer's disease-related presenilin 1 in intercellular adhesion.
-
The role of WNT10B in normal prostate gland development and prostate cancer.
-
The role of androgen deprivation therapy combined with prostate brachytherapy.
-
The role of seminal vesicle motion in target margin assessment for online image-guided radiotherapy for prostate cancer.
-
The state of prostate MRI in 2013.
-
Three-dimensional localization and targeting of prostate cancer foci with imaging and histopathologic correlation: establishing a multidisciplinary team for quality improvement.
-
Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancer.
-
Thresholds for thermal damage to normal tissues: an update.
-
Thrombin expression in prostate: a novel finding.
-
Tissue clearing techniques for three-dimensional optical imaging of intact human prostate and correlations with multi-parametric MRI.
-
Transrectal gene therapy of the prostate in the canine model.
-
Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostate.
-
Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence?
-
Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
-
US lesion visibility predicts clinically significant upgrade of prostate cancer by systematic biopsy.
-
Update on transrectal ultrasound-guided needle biopsy of the prostate.
-
Urinary outcomes are significantly affected by nerve sparing quality during radical prostatectomy.
-
Urine chemokines indicate pathogenic association of obesity with BPH/LUTS.
-
Urology Residents' Experience With Simulation: Initial Evaluation of MRI/US Fusion Biopsy Workshop.
-
Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland.
-
Use of serum creatinine to predict pathologic stage and recurrence among radical prostatectomy patients.
-
Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms.
-
Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting.
-
Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
-
Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system.
-
Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen.
-
Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel.
-
Variables in predicting survival based on treating "PSA-only" relapse.
-
Variations of focal regions versus numbers and positions of sources in two-dimensional media.
-
Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target Antigens.
-
Keywords of People
-
-
Bitting, Rhonda L,
Associate Professor of Medicine,
Medicine, Medical Oncology
-
Inman, Brant Allen,
Professor of Surgery,
Surgery, Urology
-
Nightingale, Kathryn Radabaugh,
Theo Pilkington Distinguished Professor of Biomedical Engineering,
Biomedical Engineering
-
O'Daniel, Jennifer Colleen,
Assistant Professor of Radiation Oncology,
Radiation Oncology
-
Routh, Jonathan Charles,
Paul H. Sherman, M.D. Distinguished Associate Professor of Surgery,
Pediatrics
-
Roy Choudhury, Kingshuk,
Adjunct Associate Professor in the Department of Biostatistics & Bioinformatics,
Biostatistics & Bioinformatics